Search results
5 sie 2022 · The 2004 guideline made recommendations for primary prevention (eg, maternal Rh typing and treatment) and secondary prevention (eg, risk- factor assessment and close monitoring for the development of hyperbilirubinemia, and, when necessary, treatment).
- Getting Out of The Gate
In this issue of Pediatrics, Kemper et al offer a revision...
- Getting Out of The Gate
Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.
1 cze 2007 · To predict the occurrence of severe hyperbilirubinemia, it is therefore recommended that either TSB or TcB concentration be measured in all infants between 24 h and 72 h of life; if the infant does not require immediate treatment, the results should be plotted on the predictive nomogram to determine the risk of progression to severe ...
Bhutani curve (below) is the accepted nomogram for assessing hyperbilirubinemia risk for infants ≥ 35 weeks gestation, based on bilirubin level and postnatal age © Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital
The management of neonatal jaundice includes the assessment of bilirubin laboratory values, consideration of patient-specific risk factors, and plotting on a bilirubin nomogram reference to determine risk and guide therapy.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
Neonatal jaundice. Treatment threshold graphs. NICE clinical guideline 98. Developed by the National Collaborating Centre for Women’s and Children’s Health. These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool.
